WO2023207268A1 - Procédé de synthèse d'acide désoxycholique d'origine végétale - Google Patents
Procédé de synthèse d'acide désoxycholique d'origine végétale Download PDFInfo
- Publication number
- WO2023207268A1 WO2023207268A1 PCT/CN2023/076722 CN2023076722W WO2023207268A1 WO 2023207268 A1 WO2023207268 A1 WO 2023207268A1 CN 2023076722 W CN2023076722 W CN 2023076722W WO 2023207268 A1 WO2023207268 A1 WO 2023207268A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- formula
- compound
- reaction
- solvent
- ring
- Prior art date
Links
- 229960003964 deoxycholic acid Drugs 0.000 title claims abstract description 67
- KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 title claims abstract description 67
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 title claims abstract description 67
- 238000001308 synthesis method Methods 0.000 title abstract description 9
- 238000006722 reduction reaction Methods 0.000 claims abstract description 125
- 238000005984 hydrogenation reaction Methods 0.000 claims abstract description 82
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims abstract description 46
- 238000007254 oxidation reaction Methods 0.000 claims abstract description 41
- 238000005886 esterification reaction Methods 0.000 claims abstract description 38
- 238000006297 dehydration reaction Methods 0.000 claims abstract description 33
- 238000006735 epoxidation reaction Methods 0.000 claims abstract description 33
- 238000006546 Horner-Wadsworth-Emmons reaction Methods 0.000 claims abstract description 23
- 238000007239 Wittig reaction Methods 0.000 claims abstract description 23
- 238000006460 hydrolysis reaction Methods 0.000 claims abstract description 23
- 150000001875 compounds Chemical class 0.000 claims description 550
- 238000006243 chemical reaction Methods 0.000 claims description 236
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical group ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 219
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 216
- 239000002904 solvent Substances 0.000 claims description 165
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 146
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 105
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 87
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 82
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 78
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 73
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 claims description 72
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 69
- 239000002994 raw material Substances 0.000 claims description 69
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 60
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 48
- 239000002585 base Substances 0.000 claims description 44
- 238000000034 method Methods 0.000 claims description 35
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 34
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 claims description 33
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 31
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 31
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 30
- 229960000549 4-dimethylaminophenol Drugs 0.000 claims description 26
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 25
- -1 phenyl p-Methoxyphenyl o-Methoxyphenyl 2,4-dimethoxyphenyl p-trifluoromethylphenyl Chemical group 0.000 claims description 25
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 24
- 239000007800 oxidant agent Substances 0.000 claims description 23
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 22
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 claims description 21
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 20
- 239000003153 chemical reaction reagent Substances 0.000 claims description 20
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims description 18
- 230000035484 reaction time Effects 0.000 claims description 18
- CFMZSMGAMPBRBE-UHFFFAOYSA-N 2-hydroxyisoindole-1,3-dione Chemical compound C1=CC=C2C(=O)N(O)C(=O)C2=C1 CFMZSMGAMPBRBE-UHFFFAOYSA-N 0.000 claims description 17
- 239000001257 hydrogen Substances 0.000 claims description 17
- 229910052739 hydrogen Inorganic materials 0.000 claims description 17
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 16
- 230000009471 action Effects 0.000 claims description 16
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 15
- NAWXUBYGYWOOIX-SFHVURJKSA-N (2s)-2-[[4-[2-(2,4-diaminoquinazolin-6-yl)ethyl]benzoyl]amino]-4-methylidenepentanedioic acid Chemical compound C1=CC2=NC(N)=NC(N)=C2C=C1CCC1=CC=C(C(=O)N[C@@H](CC(=C)C(O)=O)C(O)=O)C=C1 NAWXUBYGYWOOIX-SFHVURJKSA-N 0.000 claims description 14
- JWUJQDFVADABEY-UHFFFAOYSA-N 2-methyltetrahydrofuran Chemical compound CC1CCCO1 JWUJQDFVADABEY-UHFFFAOYSA-N 0.000 claims description 14
- JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical group ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 claims description 14
- 239000003638 chemical reducing agent Substances 0.000 claims description 14
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 13
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 12
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 claims description 12
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 12
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 12
- 239000007868 Raney catalyst Substances 0.000 claims description 11
- 229910000564 Raney nickel Inorganic materials 0.000 claims description 11
- 125000000217 alkyl group Chemical group 0.000 claims description 11
- 230000001590 oxidative effect Effects 0.000 claims description 11
- 239000003054 catalyst Substances 0.000 claims description 10
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 9
- 150000001242 acetic acid derivatives Chemical class 0.000 claims description 9
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 8
- 239000004342 Benzoyl peroxide Substances 0.000 claims description 8
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims description 8
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 8
- 239000003513 alkali Substances 0.000 claims description 8
- 235000019400 benzoyl peroxide Nutrition 0.000 claims description 8
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 claims description 8
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 8
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 7
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 7
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 claims description 7
- 239000011591 potassium Substances 0.000 claims description 7
- 229910052700 potassium Inorganic materials 0.000 claims description 7
- 239000008096 xylene Substances 0.000 claims description 7
- GDOPTJXRTPNYNR-UHFFFAOYSA-N methyl-cyclopentane Natural products CC1CCCC1 GDOPTJXRTPNYNR-UHFFFAOYSA-N 0.000 claims description 6
- JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 claims description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 5
- RCBVKBFIWMOMHF-UHFFFAOYSA-L hydroxy-(hydroxy(dioxo)chromio)oxy-dioxochromium;pyridine Chemical compound C1=CC=NC=C1.C1=CC=NC=C1.O[Cr](=O)(=O)O[Cr](O)(=O)=O RCBVKBFIWMOMHF-UHFFFAOYSA-L 0.000 claims description 5
- NTNUDYROPUKXNA-UHFFFAOYSA-N methyl 2-(triphenyl-$l^{5}-phosphanylidene)acetate Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)(=CC(=O)OC)C1=CC=CC=C1 NTNUDYROPUKXNA-UHFFFAOYSA-N 0.000 claims description 5
- 230000002194 synthesizing effect Effects 0.000 claims description 5
- KPZSTOVTJYRDIO-UHFFFAOYSA-K trichlorocerium;heptahydrate Chemical compound O.O.O.O.O.O.O.Cl[Ce](Cl)Cl KPZSTOVTJYRDIO-UHFFFAOYSA-K 0.000 claims description 5
- IIHPVYJPDKJYOU-UHFFFAOYSA-N triphenylcarbethoxymethylenephosphorane Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)(=CC(=O)OCC)C1=CC=CC=C1 IIHPVYJPDKJYOU-UHFFFAOYSA-N 0.000 claims description 5
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 claims description 4
- XQABVLBGNWBWIV-UHFFFAOYSA-N 4-methoxypyridine Chemical compound COC1=CC=NC=C1 XQABVLBGNWBWIV-UHFFFAOYSA-N 0.000 claims description 4
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 claims description 4
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims description 4
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 claims description 4
- LVZGQWKTUCVPBQ-UHFFFAOYSA-N acetic acid;trifluoroborane Chemical class CC(O)=O.FB(F)F LVZGQWKTUCVPBQ-UHFFFAOYSA-N 0.000 claims description 4
- 229910021529 ammonia Inorganic materials 0.000 claims description 4
- GLXDVVHUTZTUQK-UHFFFAOYSA-M lithium hydroxide monohydrate Substances [Li+].O.[OH-] GLXDVVHUTZTUQK-UHFFFAOYSA-M 0.000 claims description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 4
- IFMZTQNYAXMLFK-UHFFFAOYSA-N propyl 2-(triphenyl-$l^{5}-phosphanylidene)acetate Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)(=CC(=O)OCCC)C1=CC=CC=C1 IFMZTQNYAXMLFK-UHFFFAOYSA-N 0.000 claims description 4
- 239000011734 sodium Substances 0.000 claims description 4
- 239000012279 sodium borohydride Substances 0.000 claims description 4
- 229910000033 sodium borohydride Inorganic materials 0.000 claims description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 4
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 claims description 4
- GGUBFICZYGKNTD-UHFFFAOYSA-N triethyl phosphonoacetate Chemical compound CCOC(=O)CP(=O)(OCC)OCC GGUBFICZYGKNTD-UHFFFAOYSA-N 0.000 claims description 4
- LLJFNWVJKMVHIL-UHFFFAOYSA-N (2-methoxy-2-oxoethyl)phosphonic acid Chemical compound COC(=O)CP(O)(O)=O LLJFNWVJKMVHIL-UHFFFAOYSA-N 0.000 claims description 3
- 125000002252 acyl group Chemical group 0.000 claims description 3
- 125000003118 aryl group Chemical group 0.000 claims description 3
- PQVSTLUFSYVLTO-UHFFFAOYSA-N ethyl n-ethoxycarbonylcarbamate Chemical compound CCOC(=O)NC(=O)OCC PQVSTLUFSYVLTO-UHFFFAOYSA-N 0.000 claims description 3
- 229940040692 lithium hydroxide monohydrate Drugs 0.000 claims description 3
- CTSAXXHOGZNKJR-UHFFFAOYSA-N methyl 2-diethoxyphosphorylacetate Chemical compound CCOP(=O)(OCC)CC(=O)OC CTSAXXHOGZNKJR-UHFFFAOYSA-N 0.000 claims description 3
- XONPDZSGENTBNJ-UHFFFAOYSA-N molecular hydrogen;sodium Chemical group [Na].[H][H] XONPDZSGENTBNJ-UHFFFAOYSA-N 0.000 claims description 3
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 claims description 3
- 125000003944 tolyl group Chemical group 0.000 claims description 3
- SIAPCJWMELPYOE-UHFFFAOYSA-N lithium hydride Chemical compound [LiH] SIAPCJWMELPYOE-UHFFFAOYSA-N 0.000 claims description 2
- 229910000103 lithium hydride Inorganic materials 0.000 claims description 2
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 claims description 2
- NXJCBFBQEVOTOW-UHFFFAOYSA-L palladium(2+);dihydroxide Chemical compound O[Pd]O NXJCBFBQEVOTOW-UHFFFAOYSA-L 0.000 claims description 2
- 229910000073 phosphorus hydride Inorganic materials 0.000 claims description 2
- 229910003446 platinum oxide Inorganic materials 0.000 claims description 2
- 125000003107 substituted aryl group Chemical group 0.000 claims description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims 6
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 claims 4
- QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical compound CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 claims 3
- MJEMIOXXNCZZFK-UHFFFAOYSA-N ethylone Chemical compound CCNC(C)C(=O)C1=CC=C2OCOC2=C1 MJEMIOXXNCZZFK-UHFFFAOYSA-N 0.000 claims 2
- DVQMPWOLBFKUMM-UHFFFAOYSA-M 2-diethoxyphosphorylacetate Chemical compound CCOP(=O)(CC([O-])=O)OCC DVQMPWOLBFKUMM-UHFFFAOYSA-M 0.000 claims 1
- BVIMEFRTGPIBQR-UHFFFAOYSA-N OC(=O)C(P(O)(O)=O)(P(O)(O)=O)P(O)(O)=O Chemical compound OC(=O)C(P(O)(O)=O)(P(O)(O)=O)P(O)(O)=O BVIMEFRTGPIBQR-UHFFFAOYSA-N 0.000 claims 1
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 125000004494 ethyl ester group Chemical group 0.000 claims 1
- 150000002431 hydrogen Chemical class 0.000 claims 1
- 230000007062 hydrolysis Effects 0.000 claims 1
- 150000003949 imides Chemical class 0.000 claims 1
- AZFQCTBZOPUVOW-UHFFFAOYSA-N methyl(triphenyl)phosphanium Chemical compound C=1C=CC=CC=1[P+](C=1C=CC=CC=1)(C)C1=CC=CC=C1 AZFQCTBZOPUVOW-UHFFFAOYSA-N 0.000 claims 1
- YKYONYBAUNKHLG-UHFFFAOYSA-N n-Propyl acetate Natural products CCCOC(C)=O YKYONYBAUNKHLG-UHFFFAOYSA-N 0.000 claims 1
- 229910052759 nickel Inorganic materials 0.000 claims 1
- 229940090181 propyl acetate Drugs 0.000 claims 1
- KKCBUQHMOMHUOY-UHFFFAOYSA-N sodium oxide Chemical compound [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 claims 1
- 229910001948 sodium oxide Inorganic materials 0.000 claims 1
- 150000003457 sulfones Chemical class 0.000 claims 1
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 claims 1
- 239000007858 starting material Substances 0.000 abstract 1
- 238000003756 stirring Methods 0.000 description 138
- 238000005481 NMR spectroscopy Methods 0.000 description 133
- 238000002360 preparation method Methods 0.000 description 88
- 239000007787 solid Substances 0.000 description 87
- 238000004440 column chromatography Methods 0.000 description 80
- 239000012074 organic phase Substances 0.000 description 69
- 239000000243 solution Substances 0.000 description 52
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 46
- 239000012141 concentrate Substances 0.000 description 45
- 239000000706 filtrate Substances 0.000 description 43
- 238000000605 extraction Methods 0.000 description 39
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 31
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 30
- 238000010791 quenching Methods 0.000 description 28
- LEHBURLTIWGHEM-UHFFFAOYSA-N pyridinium chlorochromate Chemical compound [O-][Cr](Cl)(=O)=O.C1=CC=[NH+]C=C1 LEHBURLTIWGHEM-UHFFFAOYSA-N 0.000 description 26
- 238000012544 monitoring process Methods 0.000 description 24
- 238000003786 synthesis reaction Methods 0.000 description 22
- 230000015572 biosynthetic process Effects 0.000 description 18
- 239000007788 liquid Substances 0.000 description 18
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 16
- 238000004128 high performance liquid chromatography Methods 0.000 description 15
- 229910052757 nitrogen Inorganic materials 0.000 description 15
- 239000000047 product Substances 0.000 description 15
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 14
- 229920006395 saturated elastomer Polymers 0.000 description 14
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical class [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 13
- 239000007864 aqueous solution Substances 0.000 description 12
- 229940117975 chromium trioxide Drugs 0.000 description 12
- WGLPBDUCMAPZCE-UHFFFAOYSA-N chromium trioxide Inorganic materials O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 12
- GAMDZJFZMJECOS-UHFFFAOYSA-N chromium(6+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[Cr+6] GAMDZJFZMJECOS-UHFFFAOYSA-N 0.000 description 12
- 239000002244 precipitate Substances 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 8
- 238000009776 industrial production Methods 0.000 description 8
- 238000000746 purification Methods 0.000 description 8
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- MXMOTZIXVICDSD-UHFFFAOYSA-N anisoyl chloride Chemical compound COC1=CC=C(C(Cl)=O)C=C1 MXMOTZIXVICDSD-UHFFFAOYSA-N 0.000 description 6
- 230000003647 oxidation Effects 0.000 description 5
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 4
- 239000008346 aqueous phase Substances 0.000 description 4
- 239000011651 chromium Substances 0.000 description 4
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 4
- 239000005457 ice water Substances 0.000 description 4
- 239000011259 mixed solution Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- CIHOLLKRGTVIJN-UHFFFAOYSA-N tert‐butyl hydroperoxide Chemical compound CC(C)(C)OO CIHOLLKRGTVIJN-UHFFFAOYSA-N 0.000 description 4
- 239000012267 brine Substances 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000012046 mixed solvent Substances 0.000 description 3
- 229910052763 palladium Inorganic materials 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000010189 synthetic method Methods 0.000 description 3
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 2
- NOGFHTGYPKWWRX-UHFFFAOYSA-N 2,2,6,6-tetramethyloxan-4-one Chemical compound CC1(C)CC(=O)CC(C)(C)O1 NOGFHTGYPKWWRX-UHFFFAOYSA-N 0.000 description 2
- KVIUXRJCBBXEGJ-UHFFFAOYSA-N 2,4-dimethoxybenzoyl chloride Chemical compound COC1=CC=C(C(Cl)=O)C(OC)=C1 KVIUXRJCBBXEGJ-UHFFFAOYSA-N 0.000 description 2
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical group CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 2
- RZNHSEZOLFEFGB-UHFFFAOYSA-N 2-methoxybenzoyl chloride Chemical compound COC1=CC=CC=C1C(Cl)=O RZNHSEZOLFEFGB-UHFFFAOYSA-N 0.000 description 2
- OXZYBOLWRXENKT-UHFFFAOYSA-N 4-(trifluoromethyl)benzoyl chloride Chemical compound FC(F)(F)C1=CC=C(C(Cl)=O)C=C1 OXZYBOLWRXENKT-UHFFFAOYSA-N 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 150000008065 acid anhydrides Chemical group 0.000 description 2
- 210000001789 adipocyte Anatomy 0.000 description 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 2
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 2
- 210000000941 bile Anatomy 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- GBRBMTNGQBKBQE-UHFFFAOYSA-L copper;diiodide Chemical compound I[Cu]I GBRBMTNGQBKBQE-UHFFFAOYSA-L 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 229960000890 hydrocortisone Drugs 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000004130 lipolysis Effects 0.000 description 2
- XUYJLQHKOGNDPB-UHFFFAOYSA-N phosphonoacetic acid Chemical compound OC(=O)CP(O)(O)=O XUYJLQHKOGNDPB-UHFFFAOYSA-N 0.000 description 2
- 239000012312 sodium hydride Substances 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- PODWXQQNRWNDGD-UHFFFAOYSA-L sodium thiosulfate pentahydrate Chemical compound O.O.O.O.O.[Na+].[Na+].[O-]S([S-])(=O)=O PODWXQQNRWNDGD-UHFFFAOYSA-L 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- IJDMZPXMWIFWON-UHFFFAOYSA-N (2-oxo-2-propoxyethyl)phosphonic acid Chemical compound CCCOC(=O)CP(O)(O)=O IJDMZPXMWIFWON-UHFFFAOYSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 1
- MICMHFIQSAMEJG-UHFFFAOYSA-N 1-bromopyrrolidine-2,5-dione Chemical compound BrN1C(=O)CCC1=O.BrN1C(=O)CCC1=O MICMHFIQSAMEJG-UHFFFAOYSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- RVWUHFFPEOKYLB-UHFFFAOYSA-N 2,2,6,6-tetramethyl-1-oxidopiperidin-1-ium Chemical compound CC1(C)CCCC(C)(C)[NH+]1[O-] RVWUHFFPEOKYLB-UHFFFAOYSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- SNMVJSSWZSJOGL-PLOWYNNNSA-N 9alpha-hydroxyandrost-4-en-3,17-dione Chemical compound O=C1CC[C@]2(C)[C@@]3(O)CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 SNMVJSSWZSJOGL-PLOWYNNNSA-N 0.000 description 1
- 241000272517 Anseriformes Species 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 239000004380 Cholic acid Substances 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- ZHUOOEGSSFNTNP-JMKDMENQSA-N Deoxycholic acid methyl ester Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCC(=O)OC)[C@@]2(C)[C@@H](O)C1 ZHUOOEGSSFNTNP-JMKDMENQSA-N 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 208000002979 Influenza in Birds Diseases 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 241000186365 Mycobacterium fortuitum Species 0.000 description 1
- 229910018502 Ni—H Inorganic materials 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 241000194021 Streptococcus suis Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 244000037640 animal pathogen Species 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 206010064097 avian influenza Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- 229960002471 cholic acid Drugs 0.000 description 1
- 235000019416 cholic acid Nutrition 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000010701 ester synthesis reaction Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229940025708 injectable product Drugs 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 229940068065 phytosterols Drugs 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000004537 pulping Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
- C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
- C07J7/009—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by only one oxygen atom doubly bound
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
Definitions
- the invention belongs to the technical field of organic chemical synthesis and relates to a method for synthesizing deoxycholic acid using plant source 9,21-dihydroxy-20-methylpregnant-4-en-3-one 9-OH-BA as raw material.
- Deoxycholic acid is a free bile acid derived from cholic acid that loses an oxygen atom. It is a naturally occurring substance in the human body. It can clinically promote bile secretion and help break down fat.
- Commercial deoxycholic acid is mainly used for: 1. Biochemical, bacteriological and enzymatic research; 2. Lipase accelerator and anion remover; 3. "Double chin" lipolysis injection.
- deoxycholic acid (trade name Kybella) was approved by the U.S. Food and Drug Administration (FDA) as a drug for injectable lipolysis due to its excellent safety and effectiveness, making it the first of its kind to treat "double chin" The first injectable product approved for cosmetic use.
- FDA U.S. Food and Drug Administration
- deoxycholic acid can accurately destroy the cell membrane of adipocytes, lyse the adipocytes, and the outflowing fat is cleared by macrophages; whereas tissue cells such as skin and muscle contain a large amount of protein on their cell membrane surfaces. It will be broken down, thus having the effect of removing "double chin".
- deoxycholic acid is extracted from the bile of pigs, cattle, sheep or chickens and ducks. Studies have found that animal-derived products are likely to carry animal pathogens or other harmful factors, especially with the rise of mad cow disease (caused by the Nguyen virus) and sheep anthrax.
- deoxycholic acid (WO 2012/021133 A9) was synthesized with a total molar yield of 4.7% through 17 steps of reaction, as shown in Scheme 1.
- This route uses the more expensive catalyst PtO 2 , and the price of hydrocortisone raw materials is relatively high, the reaction steps are long, and the overall yield is low, so it is not suitable for industrial production.
- deoxycholic acid (CN 106146593 B, as shown in Scheme 2) was synthesized through 12 steps of reaction with a total molar yield of 22%.
- This route generates the 12-position carbonyl group of the C ring through an oxidation reaction.
- the step needs to be oxidized by TBHP first, and then oxidized by PCC. Only two oxidations can obtain compound (10), and the step of reducing the double bond of the C ring needs to be cycled three times, which is cumbersome and unnecessary. Suitable for industrial production.
- the object of the present invention is to provide a synthesis method of plant-derived deoxycholic acid.
- the invention uses plant source 9,21-dihydroxy-20-methylpregnant-4-en-3-one 9-OH-BA as raw material, and undergoes side chain oxidation reaction, Wittig or Wittig-Horner reaction, dehydration reaction, A ring and side chain double bond hydrogenation reduction reaction, esterification reaction, C epoxidation reaction, C ring double bond hydrogenation reduction reaction, C ring carbonyl reduction reaction, hydrolysis reaction steps to synthesize the deoxycholic acid; or through side chain oxidation Reaction, Wittig or Wittig-Horner reaction, dehydration reaction, A ring double bond and side chain double bond hydrogenation reduction reaction, A ring carbonyl reduction reaction, esterification reaction, C epoxidation reaction, C ring double bond hydrogenation reduction reaction, C The deoxycholic acid is synthesized through ring carbonyl reduction reaction and hydrolysis reaction
- the raw material 9,21-dihydroxy-20-methylpregnant-4-en-3-one 9-OH-BA includes but is not limited to It is obtained through biological fermentation of phytosterols or by chemical synthesis.
- the invention provides a method for synthesizing deoxycholic acid using plant source 9,21-dihydroxy-20-methylpregnant-4-en-3-one 9-OH-BA as raw material.
- the reaction process of the method includes: Not limited to the four synthesis methods shown in route (A):
- the synthetic routes are:
- R is selected from alkyl
- R 1 is selected from alkyl, aryl, substituted aryl, etc.
- R is selected from one or more of C1-C10 linear alkyl and branched chain alkyl;
- R 1 is selected from C1-C10 linear alkyl, C1-C10 branched alkyl, phenyl p-Methoxyphenyl o-Methoxyphenyl 2,4-dimethoxyphenyl p-trifluoromethylphenyl of one or more.
- R is selected from one or both of methyl and ethyl; R 1 is selected from p-methoxyphenyl
- the synthesis method of the present invention includes the following steps:
- Step (a) in the first solvent, the compound of formula (1) undergoes a side chain oxidation reaction to obtain the compound of formula (2);
- Step (b) in the second solvent, the compound of formula (2) is subjected to Wittig or Wittig-Horner reaction to obtain the compound of formula (3);
- Step (c) in a third solvent, the compound of formula (3) undergoes a dehydration reaction to obtain the compound of formula (4);
- Step (d) in the fourth solvent, the compound of formula (4) is subjected to a hydrogenation reduction reaction of the A ring and the side chain double bond to obtain the compound of formula (5);
- Step (1) in the twelfth solvent, the compound of formula (8) undergoes hydrogenation and reduction reaction of the C ring double bond to obtain the compound of formula (11) compound;
- Step (m) in the thirteenth solvent, the compound of formula (11) is subjected to the C ring carbonyl reduction reaction to obtain the compound of formula (12);
- the synthetic method of the present invention includes the following steps:
- Step (a) in the first solvent, the compound of formula (1) undergoes a side chain oxidation reaction to obtain the compound of formula (2);
- Step (b) in the second solvent, the compound of formula (2) is subjected to Wittig or Wittig-Horner reaction to obtain the compound of formula (3);
- Step (c) in a third solvent, the compound of formula (3) undergoes a dehydration reaction to obtain the compound of formula (4);
- Step (e) in the fifth solvent, the compound of formula (4) is subjected to a hydrogenation reduction reaction of the A ring double bond and the side chain double bond to obtain the compound of formula (6);
- Step (1) in the twelfth solvent, the compound of formula (8) undergoes hydrogenation and reduction reaction of the C ring double bond to obtain the compound of formula (11);
- Step (m) in the thirteenth solvent, the compound of formula (11) is subjected to the C ring carbonyl reduction reaction to obtain the compound of formula (12);
- the synthetic method of the present invention includes the following steps:
- Step (a) in the first solvent, the compound of formula (1) undergoes a side chain oxidation reaction to obtain the compound of formula (2);
- Step (b) in the second solvent, the compound of formula (2) is subjected to Wittig or Wittig-Horner reaction to obtain the compound of formula (3);
- Step (c) in a third solvent, the compound of formula (3) undergoes a dehydration reaction to obtain the compound of formula (4);
- Step (i) in the ninth solvent, the compound of formula (4) is subjected to C epoxidation reaction to obtain the compound of formula (9);
- Step (1) in the twelfth solvent, the compound of formula (8) undergoes hydrogenation and reduction reaction of the C ring double bond to obtain the compound of formula (11) compound;
- Step (m) in the thirteenth solvent, the compound of formula (11) is subjected to the C ring carbonyl reduction reaction to obtain the compound of formula (12);
- the synthetic method of the present invention includes the following steps:
- Step (a) in the first solvent, the compound of formula (1) undergoes a side chain oxidation reaction to obtain the compound of formula (2);
- Step (b) in the second solvent, the compound of formula (2) is subjected to Wittig or Wittig-Horner reaction to obtain the compound of formula (3);
- Step (1) in the twelfth solvent, the compound of formula (8) undergoes hydrogenation and reduction reaction of the C ring double bond to obtain the compound of formula (11);
- Step (m) in the thirteenth solvent, the compound of formula (11) is subjected to the C ring carbonyl reduction reaction to obtain the compound of formula (12);
- step (a) the side chain oxidation reaction is: in the first solvent, the compound of formula (1) and 2,2,6,6-tetramethylpiperidine oxide TEMPO, sodium bicarbonate , tetrabutylammonium bromide and oxidant undergo side chain oxidation reaction to obtain the compound of formula (2).
- the molar ratio of the compound of formula (1), TEMPO, sodium bicarbonate, tetrabutylammonium bromide, and oxidant is 1: (0 ⁇ 1): (0 ⁇ 20): (0 ⁇ 1): (1 ⁇ 5 ); preferably, it is 1:0.01:1.35:0.1:1.15.
- the side chain oxidation reaction is carried out under the action of an oxidant, and the oxidant is selected from N-chlorosuccinimide NCS, N-bromosuccinimide NBS, 2-iodoacylbenzoic acid IBX, dichromium One or more of the acid pyridinium salts PDC, etc.; preferably, it is N-chlorosuccinimide NCS.
- the temperature of the side chain oxidation reaction is 0-30°C; preferably, it is 0°C.
- the side chain oxidation reaction time is 3 to 8 hours; preferably, it is 6 hours.
- the synthesis steps of the compound of formula (2) include: dissolving the compound of formula (1) in the first solvent, then adding TEMPO, sodium bicarbonate, tetrabutylammonium bromide, and oxidizing agent to cause side chain oxidation Reaction to obtain the compound of formula (2).
- step (b) of the present invention the Wittig reaction is specifically: in the second solvent, the compound of formula (2) and methoxyformylmethylenetriphenylphosphine or ethoxyformylmethylenetriphenylphosphine Or propoxyformyl methylene triphenylphosphine undergoes Wittig reaction to obtain the compound of formula (3).
- the molar ratio of the compound of formula (2), methoxyformylmethylenetriphenylphosphine or ethoxyformylmethylenetriphenylphosphine or propoxyformylmethylenetriphenylphosphine is 1: ( 1 ⁇ 5); preferably, it is 1:1.5.
- the second solvent is one or more of xylene, toluene, benzene, tetrahydrofuran, heptane, hexane, etc.; preferably, it is toluene.
- the temperature of the Wittig reaction is 80-130°C; preferably, it is 110°C.
- the Wittig reaction time is 2 to 8 hours; preferably, it is 4 hours.
- the synthesis step of the compound of formula (3) includes: dissolving the compound of formula (2) in the second solvent, and then adding methoxyformylmethylenetriphenylphosphine or ethoxyformylmethylene Triphenylphosphine or propoxyformylmethylene triphenylphosphine undergoes Wittig reaction to obtain the compound of formula (3).
- the Wittig-Horner reaction is specifically: in the second solvent, the compound of formula (2) and a base, diethyl methyl phosphonoacetate or triethyl phosphonoacetate or phosphine
- the Wittig-Horner reaction occurs with diethyl propyl acylacetate to obtain the compound of formula (3).
- the molar ratio of the compound of formula (2), base, methyl phosphonoacetate diethyl ester or phosphonoacetate triethyl ester or phosphonoacetate propyl diethyl ester is 1: (1 ⁇ 5): (1 ⁇ 5 ); preferably, it is 1:1.5:1.5.
- the second solvent is selected from one or more of xylene, toluene, benzene, tetrahydrofuran, heptane, hexane, etc.; preferably, it is tetrahydrofuran.
- the base is selected from one or more of sodium hydrogen, potassium tert-butoxide, sodium tert-butoxide, sodium methoxide, sodium ethoxide, lithium hydride, etc.; preferably, it is sodium hydrogen.
- the temperature of the Wittig-Horner reaction is 0-30°C; preferably, it is 0°C.
- the Wittig-Horner reaction time is 2 to 8 hours; preferably, it is 4 hours.
- the synthesis steps of the compound of formula (3) include: adding a base to the third solvent, stirring, and then adding methyl diethyl phosphonoacetate or triethyl phosphonoacetate or propyl phosphonoacetate.
- the ester diethyl ester and the compound of formula (2) undergo Wittig-Horner reaction to obtain the compound of formula (3).
- step (c) of the present invention the dehydration reaction is specifically: in the third solvent, the compound of formula (3) undergoes a dehydration reaction with acetic anhydride and acid to obtain the compound of formula (4).
- the molar ratio of the compound of formula (3), acetic anhydride, and acid is 1: (0-8): (0.01-4); preferably, it is 1:0:0.9.
- the acid is selected from one or more of p-toluenesulfonic acid, sulfuric acid, boron trifluoride acetic acid complex, etc.; preferably, it is sulfuric acid.
- the third solvent is selected from one or more of dichloromethane, ethyl acetate, chloroform, 1,2-dichloroethane, water, acetic acid, etc.; preferably, it is dichloromethane.
- the temperature of the dehydration reaction is -40°C to 80°C; preferably, it is 0°C.
- the dehydration reaction time is 0.5 to 10 h; preferably, it is 1 h.
- the synthesis step of the compound of formula (4) includes: dissolving the compound of formula (3) in a third solvent, and then adding acid to cause a dehydration reaction to obtain the compound of formula (4).
- step (d) of the present invention the hydrogenation reduction of the A ring and side chain double bonds is specifically: in the fourth solvent, the compound of formula (4) undergoes a hydrogenation reduction reaction with Raney nickel and H 2 to obtain formula (5) compound.
- the mass ratio of the compound of formula (4) to Raney nickel is 1: (0.05-2); preferably, it is 1:1.
- the fourth solvent is selected from one or more of tetrahydrofuran, 1,4-dioxane, ethyl acetate, 2-methyltetrahydrofuran, isopropyl alcohol, methyl tert-butyl ether, toluene, etc. ; Preferably, it is tetrahydrofuran.
- the H 2 pressure of the hydrogenation and reduction reaction of the A ring and side chain double bonds is 1-60 atm; preferably, it is 40 atm.
- the temperature of the hydrogenation reduction reaction of the A ring and side chain double bonds is 20-120°C; preferably, it is 80°C.
- the time for the hydrogenation and reduction reaction of the A ring and side chain double bonds is 1 to 12 hours, preferably 3 hours.
- the synthesis steps of the compound of formula (5) include: dissolving the compound of formula (4) in a fourth solvent, adding Raney nickel, and performing a hydrogenation reduction reaction with H 2 to obtain the compound of formula (5).
- step (e) of the present invention the hydrogenation and reduction reaction of the A ring double bond and the side chain double bond is specifically: in the fifth solvent, the compound of formula (4) and palladium/carbon (Pd/C), alkali, H 2 A hydrogenation reduction reaction occurs to obtain the compound of formula (6).
- the molar ratio of the compound of formula (4) and the base is 1: (0.01-5); preferably, it is 1:0.05.
- the mass ratio of the compound of formula (4) and Pd/C is 1: (0.02-0.3); preferably, it is 1:0.05.
- the base is selected from one or more of sodium carbonate, sodium bicarbonate, ammonia, 4-methoxypyridine, pyridine, 4-dimethylaminopyridine, etc.; preferably, it is pyridine.
- the H 2 pressure of the hydrogenation and reduction reaction of the A ring double bond and the side chain double bond is 1 to 40 atm; preferably, it is 1 atm.
- the temperature of the hydrogenation and reduction reaction of the A ring double bond and the side chain double bond is 0-40°C; preferably, it is 25°C.
- the hydrogenation and reduction reaction time of the A ring double bond and the side chain double bond is 1 to 48 hours; preferably, it is 12 hours.
- the synthesis steps of the compound of formula (6) include: dissolving the compound of formula (4) in the fifth solvent, adding palladium carbon, alkali, and H 2 to perform a hydrogenation reduction reaction to obtain the compound of formula (6).
- step (f) of the present invention the A ring carbonyl reduction reaction is specifically: in the sixth solvent, the A ring carbonyl reduction reaction occurs between the compound of formula (6), cerium trichloride heptahydrate and a reducing agent to obtain formula (5 ) compound.
- the molar ratio of the compound of formula (6), cerium trichloride heptahydrate, and the reducing agent is 1: (0-2): (1-5); preferably, it is 1:1.1:2.
- the reducing agent is selected from one or more of sodium borohydride, potassium borohydride, lithium tri-tert-butoxyaluminum hydride, etc.; preferably, it is potassium borohydride.
- the temperature of the A ring carbonyl reduction reaction is -40 ⁇ 30°C; preferably, it is -10°C.
- the time for the reduction reaction of the carbonyl group of the A ring is 0.1 to 8 hours; preferably, it is 5 hours.
- the synthesis steps of the compound of formula (5) include: dissolving the compound of formula (6) in the sixth solvent, adding cerium trichloride heptahydrate and a reducing agent in sequence, and reducing the A ring carbonyl group to obtain Compounds of formula (5).
- step (g) of the present invention when the hydroxyl protecting reagent is an acid anhydride, the esterification reaction is specifically: in the seventh solvent, the compound of formula (5) undergoes an esterification reaction with the hydroxyl protecting reagent and a base to obtain formula (7) compound.
- the seventh solvent is selected from one or more of ethyl acetate, dichloromethane, chloroform, N,N-dimethylformamide, toluene, tetrahydrofuran, 2-methyltetrahydrofuran, etc.; preferably Ground, is methylene chloride.
- the base is selected from one or more of triethylamine, diisopropylethylamine, imidazole, pyridine, 4-dimethylaminopyridine, DMAP, etc.; preferably, it is DMAP.
- the molar ratio of the compound of formula (5), hydroxyl protecting reagent and base is 1:(1 ⁇ 4):(0.05 ⁇ 5); preferably, it is 1:2:0.2.
- the temperature of the esterification reaction is 0-50°C; preferably, it is 25°C.
- the time of the esterification reaction is 2 to 24 hours, preferably 8 hours.
- step (g) of the present invention when the hydroxyl protecting reagent is an acid chloride, the esterification reaction is specifically: in the seventh solvent, the compound of formula (5) undergoes an esterification reaction with the hydroxyl protecting reagent and a base to obtain formula (7) compound.
- the seventh solvent is selected from one or more of ethyl acetate, dichloromethane, chloroform, N,N-dimethylformamide, toluene, tetrahydrofuran, 2-methyltetrahydrofuran, etc.; preferably Ground, is methylene chloride.
- the base is selected from triethylamine, diisopropylethylamine, imidazole, pyridine, 4-dimethylaminopyridine DMAP, etc.
- the base is selected from triethylamine, diisopropylethylamine, imidazole, pyridine, 4-dimethylaminopyridine DMAP, etc.
- the molar ratio of the compound of formula (5), hydroxyl protecting reagent, and base is 1:(1-4):(0.05-5); preferably, it is 1:2:2.2.
- the temperature of the esterification reaction is 0-50°C; preferably, it is 25°C.
- the time of the esterification reaction is 2 to 24 hours, preferably 8 hours.
- the synthesis steps of the compound of formula (7) include: dissolving the compound of formula (5) in a seventh solvent, adding a base and a hydroxyl protecting reagent, and performing an esterification reaction to obtain the compound of formula (7).
- step (h) of the present invention the C epoxidation reaction is specifically: in the eighth solvent, the C epoxidation reaction occurs between the compound of formula (7), N-hydroxyphthalimide NHPI and an oxidant, Compounds of formula (8) are obtained.
- the eighth solvent is selected from one or more of toluene, acetone, water, methylene chloride, N,N-dimethylformamide, ethyl acetate, N-methylpyrrolidone, acetic acid, etc.; preferably The ground is acetic acid.
- the molar ratio of the compound of formula (7), oxidizing agent and N-hydroxyphthalimide is 1: (1-5): (0 ⁇ 5); preferably, it is 1:4:0.
- the oxidizing agent is selected from one or more of Na 2 Cr 2 O 7 , K 2 Cr 2 O 7 , pyridinium dichromate PDC, benzoyl peroxide BPO, CrO 3, etc.; preferably, it is CrO 3 .
- the temperature of the C epoxidation reaction is 0-50°C; preferably, it is 35°C.
- the time of the C epoxidation reaction is 10 to 48 hours; preferably, it is 12 hours.
- the synthesis steps of the compound of formula (8) include: dissolving the compound of formula (7) in the eighth solvent, adding N-hydroxyphthalimide NHPI and an oxidant, and causing C epoxidation Reaction to obtain the compound of formula (8).
- step (i) of the present invention the C epoxidation reaction is specifically: in the ninth solvent, the compound of formula (4) undergoes a C epoxidation reaction with N-hydroxyphthalimide NHPI and an oxidant, Compounds of formula (9) are obtained.
- the ninth solvent is selected from one or more of toluene, acetone, water, methylene chloride, N,N-dimethylformamide, ethyl acetate, N-methylpyrrolidone, acetic acid, etc.; preferably Ground is acetone/water.
- the molar ratio of the compound of formula (4), oxidizing agent and N-hydroxyphthalimide is 1: (1-10): (0 ⁇ 5); preferably, it is 1:3:1.
- the oxidizing agent is selected from one or more of Na 2 Cr 2 O 7 , K 2 Cr 2 O 7 , pyridinium dichromate PDC, benzoyl peroxide BPO, CrO 3, etc.; preferably, it is PDC.
- the temperature of the C epoxidation reaction is 0-50°C; preferably, it is 45°C.
- the time of the C epoxidation reaction is 10 to 48 hours; preferably, it is 12 hours.
- the synthesis step of the compound of formula (9) includes: dissolving the compound of formula (4) in the ninth solvent In, add N-hydroxyphthalimide and oxidant, C epoxidation reaction occurs, and the compound of formula (9) is obtained.
- step (j) of the present invention the hydrogenation reduction reaction of the A ring and the side chain double bond is specifically: in the tenth solvent, the compound of formula (9) undergoes a hydrogenation reduction reaction with Raney nickel and H 2 to obtain formula (10 ) compound.
- the mass ratio of the compound of formula (9) to Raney nickel is 1: (0.05-2); preferably, it is 1:1.
- the tenth solvent is selected from one or more of tetrahydrofuran, 1,4-dioxane, ethyl acetate, 2-methyltetrahydrofuran, isopropyl alcohol, methyl tert-butyl ether, toluene, etc. ; Preferably, it is tetrahydrofuran.
- the H 2 pressure of the hydrogenation and reduction reaction of the A ring and side chain double bonds is 1-60 atm; preferably, it is 40 atm.
- the temperature of the hydrogenation reduction reaction of the A ring and side chain double bonds is 20-120°C; preferably, it is 90°C.
- the time for the hydrogenation and reduction reaction of the A ring and side chain double bonds is 1 to 12 hours; preferably, it is 3 hours.
- the synthesis steps of the compound of formula (10) include: dissolving the compound of formula (9) in the tenth solvent, adding Raney nickel, and performing a hydrogenation reduction reaction under a certain H pressure to obtain the formula (10) Compounds.
- step (k) of the present invention when the hydroxyl protecting reagent is an acid anhydride, the esterification reaction is specifically: in the eleventh solvent, the compound of formula (10) undergoes an esterification reaction with the hydroxyl protecting reagent and a base to obtain the formula ( 8) Compounds.
- the eleventh solvent is selected from one or more of ethyl acetate, dichloromethane, chloroform, N,N-dimethylformamide, toluene, tetrahydrofuran, 2-methyltetrahydrofuran, etc.; Preferably, it is methylene chloride.
- the base is selected from one or more of triethylamine, diisopropylethylamine, imidazole, pyridine, 4-dimethylaminopyridine, DMAP, etc.; preferably, it is DMAP.
- the molar ratio of the compound of formula (10), hydroxyl protecting reagent, and base is 1:(1-4):(0.05-5); preferably, it is 1:2:0.2.
- the temperature of the reaction is 0-50°C; preferably, it is 25°C.
- the time of the esterification reaction is 2 to 24 hours, preferably 8 hours.
- step (k) of the present invention when the hydroxyl protecting reagent is an acid chloride, the esterification reaction is specifically: in the eleventh solvent, the compound of formula (10) undergoes an esterification reaction with the hydroxyl protecting reagent and a base to obtain the formula ( 8) Compounds.
- the eleventh solvent is selected from one or more of ethyl acetate, dichloromethane, chloroform, N,N-dimethylformamide, toluene, tetrahydrofuran, 2-methyltetrahydrofuran, etc.; Preferably, it is methylene chloride.
- the base is selected from one or more of triethylamine, diisopropylethylamine, imidazole, pyridine, 4-dimethylaminopyridine DMAP, etc.; preferably, it is a mixture of triethylamine and DMAP Base; further preferably, the molar ratio of triethylamine and DMAP is 10/1.
- the molar ratio of the compound of formula (10), hydroxyl protecting reagent and base is 1:(1 ⁇ 4):(0.05 ⁇ 5); preferably, it is 1:2:2.2.
- the temperature of the reaction is 0-50°C; preferably, it is 25°C.
- the time of the esterification reaction is 2 to 24 hours, preferably 8 hours.
- the synthesis steps of the compound of formula (8) include: dissolving the compound of formula (10) in the eleventh solvent, adding a hydroxyl protecting reagent and a base, and causing an esterification reaction to obtain the compound of formula (8) .
- step (l) of the present invention the C-ring double bond reduction reaction is specifically: in the twelfth solvent, the C-ring double bond reduction reaction occurs between the compound of formula (8) and the catalyst and H 2 to obtain the compound of formula (11) .
- the mass ratio of the compound of formula (8) to the catalyst is 1: (0.05-2); preferably, it is 1:0.2.
- the catalyst is selected from one or more of Raney nickel, palladium on carbon, platinum oxide, and palladium hydroxide; preferably, it is palladium on carbon.
- the twelfth solvent is selected from tetrahydrofuran, 1,4-dioxane, ethyl acetate, 2-methyltetrahydrofuran, isopropyl alcohol, methyl tert-butyl ether, toluene, xylene, etc.
- 1,4-dioxane 1,4-dioxane.
- the H 2 pressure of the C ring double bond reduction reaction is 20-60 atm; preferably, it is 40 atm.
- the temperature of the C ring double bond reduction reaction is 70-120°C; preferably, it is 110°C.
- the time of the C ring double bond reduction reaction is 8 to 72 hours; preferably, it is 48 hours.
- the synthesis steps of the compound of formula (11) include: dissolving the compound of formula (8) in a twelfth solvent, adding a catalyst, and performing a C ring double bond reduction reaction under a certain H 2 pressure to obtain Compound of formula (11).
- step (m) of the present invention the C ring carbonyl reduction reaction is specifically: in the thirteenth solvent, the C ring carbonyl reduction reaction occurs between the compound of formula (11) and the reducing agent to obtain the compound of formula (12).
- the molar ratio of the compound of formula (11) to the reducing agent is 1: (1-5); preferably, it is 1:1.5.
- the thirteenth solvent is selected from one or more of ethanol, methanol, ethyl acetate, methylene chloride, tetrahydrofuran, etc.; preferably, it is tetrahydrofuran.
- the reducing agent is selected from one or more of sodium borohydride, potassium borohydride, lithium tri-tert-butoxyaluminum hydride, etc.; preferably, it is lithium tri-tert-butoxyaluminum hydride.
- the temperature of the C ring carbonyl reduction reaction is -10 ⁇ 30°C; preferably, it is 0°C.
- the time for the C ring carbonyl reduction reaction is 0.5 to 24 hours; preferably, it is 12 hours.
- the synthesis steps of the compound of formula (12) include: dissolving the compound of formula (11) in the thirteenth solvent, adding a reducing agent in batches, and causing a C ring carbonyl reduction reaction to obtain the compound of formula (12) .
- step (n) of the present invention the hydrolysis reaction is specifically: in the fourteenth solvent, the compound of formula (12) undergoes a hydrolysis reaction with a base to obtain deoxycholic acid.
- the molar ratio of the compound of formula (12) and the base is 1: (1-5); preferably, it is 1:2.
- the base is selected from one or more of sodium tert-butoxide, potassium tert-butoxide, sodium ethoxide, sodium methoxide, sodium hydroxide, potassium hydroxide, lithium hydroxide, lithium hydroxide monohydrate, etc.; Preferably, it is lithium hydroxide monohydrate.
- the temperature of the hydrolysis reaction is 20-80°C; preferably, it is 25°C.
- the hydrolysis reaction time is 3 to 24 hours; preferably, it is 12 hours.
- the synthesis step of deoxycholic acid includes: dissolving the compound of formula (12) in a fourteenth solvent, adding a base, and causing a hydrolysis reaction to obtain deoxycholic acid.
- step (o) of the present invention the hydrogenation and reduction reaction of the A ring double bond and the side chain double bond is specifically: the compound of formula (3) is dissolved in the fifteenth solvent, in Pd/C, alkali and hydrogen Under the action of , a hydrogenation reduction reaction occurs to obtain the compound of formula (14).
- the molar ratio of the compound of formula (3) and the base is 1: (0-5); preferably, it is 1:0.01.
- the mass ratio of the compound of formula (3) and Pd/C is 1: (0.02-0.3); preferably, it is 1:0.05.
- the fifteenth solvent is selected from one or more of methanol, ethanol, propanol, ethyl acetate, acetone, dichloromethane, tetrahydrofuran, N,N-dimethylformamide; preferably, N,N-dimethylformamide.
- the base is selected from one or more of sodium carbonate, sodium bicarbonate, ammonia, 4-methoxypyridine, pyridine, and 4-dimethylaminopyridine; preferably, it is pyridine.
- the H 2 pressure of the hydrogenation and reduction reaction of the A ring double bond and the side chain double bond is 1 to 40 atm; preferably, it is 4 atm.
- the temperature of the hydrogenation and reduction reaction of the A ring double bond and the side chain double bond is 0-40°C; preferably, it is 25°C.
- the hydrogenation and reduction reaction time of the A ring double bond and the side chain double bond is 1 to 48 hours; preferably, it is 12 hours.
- the synthesis steps of the compound of formula (14) include: dissolving the compound of formula (3) in the fifteenth solvent, and performing a hydrogenation reduction reaction under the action of Pd/C, alkali and hydrogen to obtain the formula (14) Compounds.
- step (p) of the present invention the dehydration reaction is specifically: the compound of formula (14), acetic anhydride, and acid undergo a dehydration reaction in the sixteenth solvent to obtain the compound of formula (6).
- the molar ratio of the compound of formula (14), acetic anhydride, and acid is 1: (0-8): (0.01-4); preferably, it is 1:0:0.9.
- the acid is selected from one or more of p-toluenesulfonic acid, sulfuric acid, and boron trifluoride acetic acid complex; preferably, it is sulfuric acid.
- the sixteenth solvent is selected from one or more of dichloromethane, ethyl acetate, chloroform, 1,2-dichloroethane, and water; preferably, it is dichloromethane.
- the temperature of the dehydration reaction is -40°C to 80°C; preferably, it is 0°C.
- the dehydration reaction time is 0.5 to 10 h; preferably, it is 1 h.
- the synthesis steps of the compound of formula (6) include: dissolving the compound of formula (14) in the sixteenth solvent, and dehydration reaction occurs under the action of acetic anhydride and acid to obtain the compound of formula (6) .
- the present invention also provides new compounds, the structures of which are as follows:
- the invention also provides preparation and synthesis methods of the above new compounds (2, 3, 4, 6, 7, 8, 9, 11, 12), as well as the new compounds (2, 3, 4, 6, 7, 8, 9, 11, 12) Application in the preparation of deoxycholic acid using 9,21-dihydroxy-20-methylpregnant-4-en-3-one 9-OH-BA as a plant source raw material.
- the beneficial effects of the present invention include: in the preparation method of plant-derived deoxycholic acid of the present invention, the raw material 9,21-dihydroxy-20-methylpregnant-4-en-3-one 9-OH-BA is of plant origin.
- the raw materials avoid the risk of pathogenic bacteria and virus infection that may exist in animal-derived raw materials; and the synthesis steps are relatively short, easy to operate, high yield, and few side reactions, which facilitates the industrial production of deoxycholic acid; it solves the existing problems The problem of poor safety of deoxycholic acid products.
- the structure of the compound was determined with a nuclear magnetic resonance instrument and a high-resolution mass spectrometer; the reagents were mainly provided by Shanghai Sinopharm Chemical Reagent Company; the product was purified mainly through pulping and column chromatography; silica gel (200-300 mesh) was provided by Qingdao Ocean Chemical Plant Production.
- dichloromethane (8mL), compound of formula (5-1) (500mg, 1.28mmol) to the flask, stir to dissolve, add DMAP (32mg, 0.26mmol), triethylamine (261mg, 2.56mmol) and 4- Trifluoromethylbenzoyl chloride (534 mg, 2.56 mmol) was reacted at 25°C for 8 hours. After TLC monitoring of the reaction was complete, saturated ammonium chloride (1 mL) was added to quench the reaction, and dichloromethane (30 mL) and water (30 mL) were added for extraction.
- Patented route and method (WO 2012/021133)
- This patent uses the compound of formula (7-1) as the raw material (the 3-position hydroxyl group is protected by an acetyl group), uses acetic acid as the solvent, and undergoes an oxidation reaction under the action of CrO 3. The reaction is carried out at 60°C for 36 hours. The raw material is completely converted. The literature reaction yield is 60.5%.
- the present invention has discovered through many experiments that the acetyl group at position 3 of the compound of formula (7-1) is replaced with p-methoxybenzoyl group, that is, p-methoxybenzoyl chloride and the 3-position group of the compound of formula (5-1) are used.
- the compound of formula (7-2) is obtained by reacting the hydroxyl group at the position.
- the compound of formula (7-2) undergoes oxidation reaction under the action of CrO 3 in acetic acid solvent. After reaction at 35°C for 12 hours, the raw material is completely converted and the product yield can reach 92.3%. (See Example 10-(3)), and the reaction temperature is low and the reaction time is short, which is more conducive to industrial production.
- the present invention has shown through many tests that the selection of the 3-position hydroxyl protecting group has an important influence on the oxidation reaction of the C ring; when the 3-position hydroxyl protecting group is an aromatic acyl group, it is consistent with the 3-position hydroxyl protection in the patented route (WO 2012/021133).
- the aromatic acyl protecting group at the 3-position is more conducive to the oxidation reaction at the ⁇ position of the C-ring double bond, with a higher yield and shorter time.
- Patented route and method (CN 106146593 B)
- This patent uses the compound of formula (7-4) as raw material (the 3-position hydroxyl group is protected with benzoyl group), uses acetonitrile as the solvent, and undergoes an oxidation reaction under the action of copper iodide and tert-butyl hydrogen peroxide TBHP at 50°C After reacting for 24 hours, the raw materials were completely converted to obtain a mixture of the compound of formula (8-4) and the formula (15-4); then the mixture was oxidized with PCC, and the compound of formula (15-4) was converted into the compound of formula (8-4). Finally, the molar yield of the compound of formula (8-4) was 71%.
- the present invention uses the compound of formula (7-4) as the raw material, acetic acid as the solvent, and an oxidation reaction occurs under the action of CrO 3. After the reaction at 35°C for 12 hours, the raw material is completely converted, and the product molar yield can reach 87% (see Example 10- (6)); In addition, when the substituent of the 3-position hydroxyl group in the A ring is p-methoxybenzoyl, the molar yield of the oxidation reaction can reach more than 92% (see Example 9-(3)).
- the oxidation method discovered through many experiments in the present invention has higher oxidant efficiency, high yield, simple operation, short reaction time, and is more conducive to industrial production.
- This document uses the compound of formula (1) as the raw material, ethyl acetate as the solvent, reacts at 30°C under the action of 10% Pd/CH 2 (1 atm), and purifies by column chromatography to obtain the formula with a molar yield of 75.8%.
- (2) Compounds We tried this literature method, using the compound of formula (10-1) as raw material, 10% Pd/C as the catalyst, and hydrogenation reduction reaction at 30°C for 24 hours. The target compound of formula (14-1) was not detected in the reaction solution. In subsequent experiments, we increased the reaction temperature and hydrogen pressure, and tried to use Raney Ni-H 2 or 10% Pd/CH 2 to hydrogenate the C ring carbonyl group and double bond.
- the main product in the reaction solution was the compound of formula (13) (including the formula (13-1) and formula (13-2) compounds), there are a small amount of formula (14) compounds (including formula (14-1) and formula (14-2) compounds); and these four compounds have similar polarities and are relatively Difficult to isolate and purify.
- formula (13) including the formula (13-1) and formula (13-2) compounds
- formula (14) compounds including formula (14-1) and formula (14-2) compounds
- the present invention protects the 3-position hydroxyl group, hydrogenates and reduces the C ring carbonyl group and double bond, and then oxidizes the target compound to obtain a high yield and easy separation and purification.
- the compound of formula (8-2) is used as a raw material (that is, the compound of formula (8-2) is obtained by reacting p-methoxybenzoyl chloride with the 3-hydroxyl group of the compound of formula (10-1)) as a raw material, and 1,4-bis Oxyhexanes were used as solvents, and the reaction was carried out at 110°C for 24 hours under the action of 10% Pd/CH 2.
- the reaction solution was oxidized by PCC to obtain the compound of formula (11-2), the product of the hydrogenation reduction of the C-ring double bond, with a molar yield of 90.1 % (see Example 11-(2)).
- the present invention first protects the hydroxyl group of the A ring with acetyl, p-methoxybenzoyl and other protecting groups, and then attempts to hydrogenate and reduce the carbonyl group and double bond of the C ring. After screening different 3-position hydroxyl substituents, catalysts, solvents, temperatures, hydrogen pressure and other conditions, the target compound was finally obtained with a higher yield.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
L'invention concerne un procédé de synthèse d'acide désoxycholique qui permet la synthèse de l'acide désoxycholique à partir de 9-OH-BA d'origine végétale en tant que matériau de départ et comprenant les étapes suivantes : réaction d'oxydation de chaîne latérale ; réaction de Wittig ou de Wittig-Horner ; réaction de déshydratation ; réaction d'hydrogénation ; réaction d'estérification ; réaction de C époxydation ; réaction de réduction de carbonyle ; réaction d'hydrolyse et analogues.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210446149 | 2022-04-26 | ||
CN202210446149.7 | 2022-04-26 | ||
CN202310058820.5 | 2023-01-17 | ||
CN202310058820.5A CN116947953A (zh) | 2022-04-26 | 2023-01-17 | 一种植物源脱氧胆酸的合成方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2023207268A1 true WO2023207268A1 (fr) | 2023-11-02 |
Family
ID=88450051
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2023/076722 WO2023207268A1 (fr) | 2022-04-26 | 2023-02-17 | Procédé de synthèse d'acide désoxycholique d'origine végétale |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN116947953A (fr) |
WO (1) | WO2023207268A1 (fr) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106146593A (zh) * | 2015-04-14 | 2016-11-23 | 南京诺瑞特医药科技有限公司 | 一种制备去氧胆酸的方法 |
CN112341516A (zh) * | 2020-11-14 | 2021-02-09 | 湖南科瑞生物制药股份有限公司 | 5,6-环氧类固醇类化合物及其制备方法和应用 |
CN114716497A (zh) * | 2021-01-05 | 2022-07-08 | 苏州盛迪亚生物医药有限公司 | 一种制备脱氧胆酸的方法 |
CN115466300A (zh) * | 2022-10-18 | 2022-12-13 | 湖南科瑞生物制药股份有限公司 | 一种胆酸中间体a7及其合成方法 |
CN115611962A (zh) * | 2022-10-18 | 2023-01-17 | 湖南科瑞生物制药股份有限公司 | 胆酸的合成方法 |
-
2023
- 2023-01-17 CN CN202310058820.5A patent/CN116947953A/zh active Pending
- 2023-02-17 WO PCT/CN2023/076722 patent/WO2023207268A1/fr unknown
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106146593A (zh) * | 2015-04-14 | 2016-11-23 | 南京诺瑞特医药科技有限公司 | 一种制备去氧胆酸的方法 |
CN112341516A (zh) * | 2020-11-14 | 2021-02-09 | 湖南科瑞生物制药股份有限公司 | 5,6-环氧类固醇类化合物及其制备方法和应用 |
CN114716497A (zh) * | 2021-01-05 | 2022-07-08 | 苏州盛迪亚生物医药有限公司 | 一种制备脱氧胆酸的方法 |
CN115466300A (zh) * | 2022-10-18 | 2022-12-13 | 湖南科瑞生物制药股份有限公司 | 一种胆酸中间体a7及其合成方法 |
CN115611962A (zh) * | 2022-10-18 | 2023-01-17 | 湖南科瑞生物制药股份有限公司 | 胆酸的合成方法 |
Also Published As
Publication number | Publication date |
---|---|
CN116947953A (zh) | 2023-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2021258723A1 (fr) | Procédé de synthèse d'acide lithocholique à l'aide de ba comme matière première | |
WO2021109791A1 (fr) | Procédé pour la synthèse d'acide ursodésoxycholique à l'aide de ba comme matière première | |
CN101279997B (zh) | 布地奈德的一种制备方法 | |
CN114874277B (zh) | 一种胆固醇的合成方法 | |
WO2022213805A1 (fr) | Procédé de synthèse du cholestérol à l'aide de ba comme matière première | |
WO2023142888A1 (fr) | Procédé de synthèse de cholestérol dérivé d'une plante de haute pureté | |
WO2023142890A1 (fr) | Procédé de synthèse de cholestérol de haute pureté | |
CN107163073A (zh) | 一种二价铜催化制备有机硅化合物及β‑羟基化合物的方法 | |
CN113135971B (zh) | 一种失碳胆甾醛及其制备方法和用途 | |
WO2023207268A1 (fr) | Procédé de synthèse d'acide désoxycholique d'origine végétale | |
CN115536719B (zh) | 一种高纯度植物源7-酮基石胆酸的合成方法 | |
CA2178479C (fr) | Derive de chromanne | |
CN115466300A (zh) | 一种胆酸中间体a7及其合成方法 | |
CN103360455A (zh) | 一种5α-雄甾-2-烯-17-酮的工业化制备方法 | |
CN115611962A (zh) | 胆酸的合成方法 | |
CN107663221A (zh) | 一种奥贝胆酸的制备方法 | |
CN113461764A (zh) | 一种熊去氧胆酸的合成方法 | |
CN111704645B (zh) | 戴斯马丁试剂在合成Ocotillol型皂苷衍生物关键中间体中的应用 | |
CN114716497A (zh) | 一种制备脱氧胆酸的方法 | |
CN111018936A (zh) | 一种氟维司群有关物质e的合成方法 | |
CN108191939A (zh) | 一种制备奥贝胆酸中间体及奥贝胆酸的方法 | |
CN106632569A (zh) | 一种薯蓣皂素衍生物的合成方法 | |
CN108250262A (zh) | 一种制备奥贝胆酸的方法 | |
CN108440395A (zh) | 一种米力农杂质的制备方法 | |
CN109988297A (zh) | 一种烷基化聚乙二醇化奥沙利铂前体的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 23794704 Country of ref document: EP Kind code of ref document: A1 |